ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+8.45%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$17.4M
AUM Growth
+$17.4M
(-84%)
Cap. Flow
-$98.8M
Cap. Flow
% of AUM
-566.33%
Top 10 Holdings %
Top 10 Hldgs %
70.1%
Holding
52
New
9
Increased
–
Reduced
16
Closed
27
Top Buys
| 1 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$1.55M |
| 2 |
Icon
ICLR
|
$1.04M |
| 3 |
Labcorp
LH
|
$906K |
| 4 |
Encompass Health
EHC
|
$859K |
| 5 |
Pfizer
PFE
|
$455K |
Top Sells
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$16.9M |
| 2 |
Bruker
BRKR
|
$6.93M |
| 3 |
AstraZeneca
AZN
|
$6.53M |
| 4 |
Thermo Fisher Scientific
TMO
|
$5.34M |
| 5 |
Elevance Health
ELV
|
$5.13M |
Sector Composition
| 1 | Healthcare | 98.36% |
| 2 | Real Estate | 1.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Boston Scientific
BSX
$156B
| $2.26M | 12.96% | 39,108 -8,785 | -18% | -$508K |
|
|
2
Thermo Fisher Scientific
TMO
$186B
| $2.01M | 11.55% | 3,794 -10,055 | -73% | -$5.34M |
|
|
AXNX
3
DELISTED
Axonics, Inc. Common Stock
AXNX
| $1.55M | 8.87% | +24,871 | New | +$1.55M |
|
|
4
Elevance Health
ELV
$71.8B
| $1.24M | 7.1% | 2,627 -10,874 | -81% | -$5.13M |
|
|
5
Icon
ICLR
$13.8B
| $1.04M | 5.94% | +3,659 | New | +$1.04M |
|
|
6
Labcorp
LH
$23.1B
| $906K | 5.19% | +3,984 | New | +$906K |
|
|
7
Encompass Health
EHC
$12.3B
| $859K | 4.92% | +12,870 | New | +$859K |
|
8
Insulet
PODD
$23.9B
| $848K | 4.86% | 3,906 -4,972 | -56% | -$1.08M |
|
9
Hologic
HOLX
$14.9B
| $831K | 4.76% | 11,631 -6,119 | -34% | -$437K |
|
10
Zimmer Biomet
ZBH
$21B
| $687K | 3.94% | 5,646 -11,833 | -68% | -$1.44M |
|
11
Avantor
AVTR
$9.18B
| $562K | 3.22% | 24,598 -202,279 | -89% | -$4.62M |
|
12
Tenet Healthcare
THC
$16.3B
| $552K | 3.16% | 7,303 -19,848 | -73% | -$1.5M |
|
|
13
Pfizer
PFE
$141B
| $455K | 2.61% | +15,790 | New | +$455K |
|
|
14
BioMarin Pharmaceuticals
BMRN
$11.2B
| $448K | 2.57% | 4,650 -174,918 | -97% | -$16.9M |
|
15
OrthoPediatrics
KIDS
$536M
| $437K | 2.5% | 13,428 -56,936 | -81% | -$1.85M |
|
16
Cigna
CI
$80.3B
| $414K | 2.38% | 1,384 -4,699 | -77% | -$1.41M |
|
17
QuidelOrtho
QDEL
$1.95B
| $379K | 2.17% | 5,147 -21,600 | -81% | -$1.59M |
|
18
Cooper Companies
COO
$13.4B
| $374K | 2.14% | 988 -10,545 | -91% | -$3.99M |
|
19
Sabra Healthcare REIT
SBRA
$4.58B
| $286K | 1.64% | 20,017 -183,775 | -90% | -$2.62M |
|
20
Agilent Technologies
A
$35.7B
| $264K | 1.51% | +1,900 | New | +$264K |
|
21
Fortrea Holdings
FTRE
$894M
| $244K | 1.4% | +6,988 | New | +$244K |
|
22
Qiagen
QGEN
$10.1B
| $227K | 1.3% | +5,219 | New | +$227K |
|
23
Humana
HUM
$36.5B
| $215K | 1.23% | 469 -6,115 | -93% | -$2.8M |
|
24
Cencora
COR
$56.5B
| $203K | 1.17% | 990 -10,616 | -91% | -$2.18M |
|
25
Aclaris Therapeutics
ACRS
$209M
| $156K | 0.89% | +148,400 | New | +$156K |
|